Immunology, Internal medicine, Autoantibody, Fibrosis and Connective tissue disease are his primary areas of study. In general Immunology, his work in Autoimmune disease, CD19, Lupus erythematosus and Immune system is often linked to Peripheral blood mononuclear cell linking many areas of study. His research integrates issues of Gastroenterology and Endocrinology in his study of Internal medicine.
His Autoantibody research includes themes of Systemic scleroderma, Autoimmunity, Antigen and Single-nucleotide polymorphism. His Fibrosis research is multidisciplinary, incorporating perspectives in CTGF, Connective tissue, Cytokine and Bleomycin. His Connective tissue disease research is multidisciplinary, relying on both Systemic disease and Scleroderma.
Minoru Hasegawa mostly deals with Immunology, Internal medicine, Pathology, Connective tissue disease and Fibrosis. His Immunology study often links to related topics such as Dermatomyositis. His Internal medicine study combines topics in areas such as Gastroenterology and Endocrinology.
His study in Connective tissue disease is interdisciplinary in nature, drawing from both Scleroderma, Systemic disease, Immunopathology and Pulmonary fibrosis, Lung. The Fibrosis study combines topics in areas such as Cancer research, Growth factor and Bleomycin. As part of the same scientific family, he usually focuses on Autoantibody, concentrating on B cell and intersecting with CD19.
His primary areas of investigation include Dermatology, Immunology, Fibrosis, Pathology and Cancer research. He interconnects Internal medicine and Linkage disequilibrium in the investigation of issues within Immunology. His Internal medicine study incorporates themes from Erythema induratum and Oncology.
The various areas that Minoru Hasegawa examines in his Fibrosis study include Biomarker, Transforming growth factor, Autoimmune disease and Growth factor. His biological study spans a wide range of topics, including In vivo, Antibody and Antigen. His research investigates the link between Immune system and topics such as B cell that cross with problems in Autoantibody.
His primary scientific interests are in Immunology, Dermatology, Pharmacology, Internal medicine and Wound burn. His Immunology research incorporates elements of Fibrosis, Linkage disequilibrium and CD80. His research in Dermatology intersects with topics in Pain management, Patient positioning, Rheumatoid arthritis and Pathology.
His studies deal with areas such as Endocrinology and Oncology as well as Internal medicine. His Autoantibody study combines topics from a wide range of disciplines, such as Scleroderma, Immune system and B cell, Regulatory B cells. Minoru Hasegawa has researched Scleroderma in several fields, including Autoimmune disease and B-cell activating factor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis.
Hasegawa M;Fujimoto M;Kikuchi K;Takehara K.
The Journal of Rheumatology (1997)
Quantitative Genetic Variation in CD19 Expression Correlates with Autoimmunity
Shinichi Sato;Minoru Hasegawa;Manabu Fujimoto;Thomas F. Tedder.
Journal of Immunology (2000)
Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy
K. Kaji;M. Fujimoto;M. Hasegawa;M. Kondo.
Altered blood B lymphocyte homeostasis in systemic sclerosis: Expanded naive B cells and diminished but activated memory B cells
Shinichi Sato;Manabu Fujimoto;Minoru Hasegawa;Kazukiko Takehara.
Arthritis & Rheumatism (2004)
Mouse CD20 expression and function.
Junji Uchida;Youngkyun Lee;Minoru Hasegawa;Yinghua Liang.
International Immunology (2004)
Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis.
Shinichi Sato;Minoru Hasegawa;Kazuhiko Takehara.
Journal of Dermatological Science (2001)
Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
Shinichi Sato;Tetsuya Nagaoka;Minoru Hasegawa;Takuya Tamatani.
The Journal of Rheumatology (2000)
CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse.
Eriko Saito;Manabu Fujimoto;Minoru Hasegawa;Kazuhiro Komura.
Journal of Clinical Investigation (2002)
Elevated serum BAFF levels in patients with systemic sclerosis: Enhanced BAFF signaling in systemic sclerosis B lymphocytes
Takashi Matsushita;Minoru Hasegawa;Koichi Yanaba;Masanari Kodera.
Arthritis & Rheumatism (2006)
Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study.
Yasuhito Hamaguchi;Masataka Kuwana;Kana Hoshino;Minoru Hasegawa.
Archives of Dermatology (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: